Assignee
GARBUZOVA DAVIS SVITLANA
US·5 granted patents·1 pending application·1 citations·filing 2005–2019
Top patents by PatentIndex Score
6 records- 0169US11007230B1Plasma derived from human umbilical cord blood for the treatment of neurodegenerative disordersGARBUZOVA DAVIS SVITLANA·Filed 2016·Granted May 18, 2021·1 cites·10 claims
- 0264US11628190B2Plasma derived from human umbilical cord blood for the treatment of neurodegenerative disordersGARBUZOVA DAVIS SVITLANA·Filed 2019·Granted Apr 18, 2023·0 cites·6 claims
- 0359US9173907B2Method of prenatal administration of mammalian umbilical cord stem cells for the intrauterine treatment of sanfilippo syndromeGARBUZOVA-DAVIS SVITLANA·Filed 2008·Granted Nov 3, 2015·0 cites·10 claims
- 0444US2018250341A1Method of repairing damaged blood-spinal cord barrier (bscb)GARBUZOVA DAVIS SVITLANA·Filed 2018·Application pending·0 cites
- 0542US8765119B2Treating amyotrophic lateral sclerosis (ALS)with isolated aldehyde dehydrogenase-positive umbilical cord blood cellsGARBUZOVA-DAVIS SVITLANA·Filed 2005·Granted Jul 1, 2014·0 cites·10 claims
- 0635US10285935B2Non-invasive method for direct delivery of therapeutics to the spinal cord in the treatment of spinal cord pathologyGARBUZOVA DAVIS SVITLANA·Filed 2016·Granted May 14, 2019·0 cites·4 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →